Comments
Loading...

Marker Therapeutics

MRKRNASDAQ
Logo brought to you by Benzinga Data
$3.73
-0.07-1.84%
Pre-Market: Dec 20, 6:43 AM EDT
Consensus Rating1
Buy
Highest Price Target1
$19.00
Lowest Price Target1
$1.00
Consensus Price Target1
$10.00

Marker Therapeutics (NASDAQ:MRKR) Stock, Analyst Ratings, Price Targets, Forecasts

Marker Therapeutics Inc has a consensus price target of $10 based on the ratings of 2 analysts. The high is $19 issued by Ladenburg Thalmann on October 21, 2024. The low is $1 issued by Roth Capital on February 17, 2022. The 3 most-recent analyst ratings were released by Ladenburg Thalmann, Ladenburg Thalmann, and Roth Capital on October 21, 2024, April 30, 2024, and February 17, 2022, respectively. With an average price target of $10.33 between Ladenburg Thalmann, Ladenburg Thalmann, and Roth Capital, there's an implied 171.93% upside for Marker Therapeutics Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Oct
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.5
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Ladenburg Thalmann
Roth Capital

1calculated from analyst ratings

Analyst Ratings for Marker Therapeutics

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Marker Therapeutics (MRKR) stock?

A

The latest price target for Marker Therapeutics (NASDAQ:MRKR) was reported by Ladenburg Thalmann on October 21, 2024. The analyst firm set a price target for $19.00 expecting MRKR to rise to within 12 months (a possible 409.38% upside). 2 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Marker Therapeutics (MRKR)?

A

The latest analyst rating for Marker Therapeutics (NASDAQ:MRKR) was provided by Ladenburg Thalmann, and Marker Therapeutics maintained their buy rating.

Q

When was the last upgrade for Marker Therapeutics (MRKR)?

A

There is no last upgrade for Marker Therapeutics

Q

When was the last downgrade for Marker Therapeutics (MRKR)?

A

The last downgrade for Marker Therapeutics Inc happened on February 17, 2022 when Roth Capital changed their price target from $3 to $1 for Marker Therapeutics Inc.

Q

When is the next analyst rating going to be posted or updated for Marker Therapeutics (MRKR)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Marker Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Marker Therapeutics was filed on October 21, 2024 so you should expect the next rating to be made available sometime around October 21, 2025.

Q

Is the Analyst Rating Marker Therapeutics (MRKR) correct?

A

While ratings are subjective and will change, the latest Marker Therapeutics (MRKR) rating was a maintained with a price target of $11.00 to $19.00. The current price Marker Therapeutics (MRKR) is trading at is $3.73, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch